Prevalence and risk factors for colonisation with extended spectrum β-lactamase producing enterobacteriacae vis-à-vis usage of antimicrobials

Indian Journal of Medical Microbiology

Volumn 28, Issue 3, 2010, Pages 217-220

  Sarma, J B ^a   Ahmed, G U ^b  

^a NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^b GAUHATI UNIVERSITY   (India)

Author keywords

Antibiotic consumption; ESBL producing enterobacteriacae; infection control

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; NETILMICIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CITROBACTER FREUNDII; DRUG USE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; HOSPITALIZATION; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; NONHUMAN; ORTHOPEDICS; PREVALENCE; PROTEUS MIRABILIS; PSORIASIS VULGARIS; RISK FACTOR; SURGERY; TEACHING HOSPITAL; ADULT; BIOSYNTHESIS; DRUG UTILIZATION; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; INDIA; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG UTILIZATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, TEACHING; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RISK FACTORS;

EID: 77955106960     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.66476     Document Type: Article

References (21)

1. Medeiros AA. Evolution and dissemination of P-lactamases accelerated by generations of P-lactam antibiotics. Clin Infect Dis 1997;24:S19-45.
2. Bonnet R. Growing group of extended-spectrum beta- lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
3. Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid- mediated extended-spectrum B-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiology 2001;201:237-241
4. Paterson DL, Bonomo RA. Extended-Spectrum P-Lactamases: a Clinical Update. Clin Microbiol Rev 2005;18:657-686
5. Perry JD, Ford M, Hjersing N, Gould FK. Rapid conventional scheme for biochemical identification of antibiotic resistance Enterobacteriacea isolates from urine. J Clin Pathol 1988;41:1010-1012
6. Pattyn SR, Sion JP, Verhoeven J. Evaluation of the LOGIC system for the Rapid Identification of Members of the Family Enterobacteriacea in the Clinical Microbiology laboratory. J Clin Microbiol 1990;28:1449-1450
7. BSAC Standardized Disc Susceptibility Testing Method. http://www.bsac.org.uk/susceptibility-testing/bsac- standardized-disc- susceptibility-method.cfm
8. Livermore DM, Winstanley TG, Shannon KP. Interpretive reading: recognising the unusual and interfering resistance mechanism from resistance phenotypes. J Antimicrob Chemother 2001;48:87-102.
9. Livermore DM, Brown DF. Detection of P-lactamase- mediated resistance. J Antimicrob Chemother 2001;48:59-64.
10. Tzelepi E, Giakkoupi P, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of Extended-Spectrum P-Lactamases in clinical isolates of enterobacter cloacae and enterobacter aerogenes. J Clin Microbiol 2000;38:542-546
11. ATC classification index with DDD. WHO Collaborating Centre for Drug Statistics Methodology, 2002.
12. Monnet DL. ABC Calc- Antibiotic consumption calculator (Version1.8). Statens Serum Institute, 2002.
13. Paterson DL, Bonomo RA. Extended-Spectrum P-Lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-686
14. Asensio A, Oliver A, Gonzalez-Diego P, Baquero F, Perez- Diaz JC, Ros P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000;30:55-60.
15. Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, et al. Extended- spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002;28:1718-1723
16. Eveillard M, Schmit JL, EB F. Antimicrobial use prior to the acquisition of multiresistant bacteria. Infect Control Hosp Epidemiol 2002;23:155-158
17. De Champs C, Rouby D, Guelon D, Sirot J, Sirot D, Beytout D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991;18:5-13.
18. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producine Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-1171
19. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999;281:517-523
20. Livermore DM, Winstanley TG, Shannon KP. Interpretive reading: recognising the unusual and interfering resistance mechanism from resistance phenotypes. J Antimicrob Chemother 2001;48:87-102.
21. Archibald LK, Reller LB. Clinical microbiology in developing countries. Emerg Infect Dis 2001;7:302-305